CADAS138 emerges as a novel therapeutic target in the realm of chronic illnesses. Preclinical studies indicate significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers are https://robertftqi865441.pointblog.net/a-novel-therapeutic-target-90587935